Depakine
Depakine is a medicine authorised by Swissmedic under authorisation number 34734. The authorisation holder is Sanofi-Aventis (Suisse) SA. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 03 May 1972 and the authorisation is valid without a time limit. ATC code N03AG01 places the medicine in the group Antiepileptics.
| Authorisation number | 34734 |
|---|---|
| Name | Depakine |
| Full name | Depakine, solution buvable |
| Authorisation holder | Sanofi-Aventis (Suisse) SA |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | N03AG01 |
| First authorisation | 03 May 1972 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 2 | Depakine, solution buvable | B | 14 June 2013 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 12 | 60 | ml | N03AG01 | 01.07.1. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Depakine authorised in Switzerland?
Yes. Depakine is authorised by Swissmedic under authorisation number 34734, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Depakine have?
Depakine is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Depakine?
The authorisation holder is Sanofi-Aventis (Suisse) SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.